Neutralization of MMP-2 protects Staphylococcus aureus infection induced septic arthritis in mice and regulates the levels of cytokines

Microbial Pathogenesis

Volumn 99, Issue , 2016, Pages 148-161

  Sultana, Sahin ^a   Adhikary, Rana ^a   Nandi, Ajeya ^a   Bishayi, Biswadev ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Inflammation; MMP 2; S. aureus; Septic arthritis; TNF

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; N[(1,1' BIPHENYL) 4 YLSULFONYL]DEXTRO PHENYLALANINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL LOAD; BACTERIAL STRAIN; BLOOD; CELL DESTRUCTION; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HOST CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STAPHYLOCOCCUS INFECTION; SYNOVIUM; URIC ACID BLOOD LEVEL; ZYMOGRAPHY; ANIMAL; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFECTIOUS ARTHRITIS; METABOLISM; PATHOLOGY; SECRETION (PROCESS); STAPHYLOCOCCUS AUREUS;

ANIMALS; ARTHRITIS, INFECTIOUS; CYTOKINES; DISEASE MODELS, ANIMAL; MATRIX METALLOPROTEINASE 2; MICE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84983803029     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.08.021     Document Type: Article

References (66)

1. [1] Goldenberg, D.L., Reed, J.I., Bacterial arthritis. N. Engl. J. Med. 312 (1985), 764–771.
2. [2] Verdrengh, M., Carlsten, H., Ohlsson, C., Tarkowski, A., Rapid systemic bone resorption during the course of Staphylococcus aureus-induced arthritis. J. Infect. Dis. 194 (2006), 1597–1600.
3. [3] Bremell, T., Tarkowski, A., Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect. Immun. 63 (1995), 4185–4187.
4. [4] Canvin, J.M., Goutcher, S.C., Hagig, M., Gemmell, C.G., Sturrock, R.D., Persistence of Staphylococcus aureus as detected by polymerase chain reaction in the synovial fluid of a patient with septic arthritis. Br. J. Rheumatol. 36 (1997), 203–206.
5. [5] Darley, E.S., MacGowan, A.P., Antibiotic treatment of gram-positive bone and joint infections. J. Antimicrob. Chemother. 53 (2004), 928–935.
6. [6] Nair, S.P., Williams, R.J., Henderson, B., Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection. Rheumatol. Oxf. 39 (2000), 821–834.
7. [7] Nizet, V., Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120 (2007), 13–22.
8. [8] Dutta, S., Bishayi, B., Effects of ciprofloxacin in combination with either aminoguanidine or meclofenamic acid in modulating S. aureus induced septic arthritis in mice. Int. J. Pharm. Pharm. Sci. 7 (2015), 355–361.
9. [9] Mal, P., Ghosh, D., Bandyopadhyay, D., Dutta, K., Bishayi, B., Ampicillin alone and in combination with riboflavin modulates Staphylococcus aureus infection induced septic arthritis in mice. Indian J. Exp. Biol. 50 (2012), 677–689.
10. [10] Mal, P., Dutta, K., Bandyopadhyay, D., Basu, A., Khan, R., Bishayi, B., Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm. Res. 62 (2013), 259–273.
11. [11] Gomis-Rüth, F.X., Catalytic domain architecture of metzincin metalloproteases. J. Biol. Chem. 284 (2009), 15353–15357.
12. [12] Puente, X.S., Sánchez, L.M., Overall, C.M., López-Otín, C., Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4 (2003), 544–558.
13. [13] Page-McCaw, A., Ewald, A.J., Werb, Z., Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8 (2007), 221–233.
14. [14] Gjertsson, I., Innocenti, M., Matrisian, L.M., Tarkowski, A., Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb. Pathog. 38 (2005), 97–105.
15. [15] Heilpern, A.J., Wertheim, W., He, J., Perides, G., Bronson, R.T., Hu, L.T., Matrix metalloproteinase 9 plays a key role in Lyme arthritis but not in dissemination of Borrelia burgdorferi. Infect. Immun. 77 (2009), 2643–2649.
16. [16] Burrage, P.S., Mix, K.S., Brinckerhoff, C.E., Matrix metalloproteinases: role in arthritis. Front. Biosci. 11 (2006), 529–543.
17. [17] Kanangat, S., Postlethwaite, A., Hasty, K., Kang, A., Smeltzer, M., Appling, W., et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res. Ther., 8, 2006, R176.
18. [18] Brenner, D.A., O'Hara, M., Angel, P., Chojkier, M., Karin, M., Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337 (1989), 661–663.
19. [19] Unemori, E.N., Hibbs, M.S., Amento, E.P., Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88 (1991), 1656–1662.
20. [20] Bartok, B., Firestein, G.S., Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233 (2010), 233–255.
21. [21] Busti, C., Falcinelli, E., Momi, S., Gresele, P., Matrix metalloproteinases and peripheral arterial disease. Intern Emerg. Med. 5 (2010), 13–25.
22. [22] Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K., et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59 (2000), 455–461.
23. [23] Fietz, S., Einspanier, R., Hoppner, S., Hertsch, B., Bondzio, A., Determination of MMP-2 and MMP-9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays. Equine Vet. J. 40 (2008), 266–271.
24. [24] Scian, R., Barrionuevo, P., Giambartolomei, G.H., De Simone, E.A., Vanzulli, S.I., Fossati, C.A., et al. Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases. Infect. Immun. 79 (2011), 3619–3632.
25. [25] Itoh, T., Matsuda, H., Tanioka, M., Kuwabara, K., Itohara, S., Suzuki, R., The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J. Immunol. 169 (2002), 2643–2647.
26. [26] Martignetti, J.A., Al Aqeel, A., Al Sewairi, W., Boumah, C.E., Kambouris, M., Al Mayouf, S., et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 28 (2001), 261–265.
27. [27] Bruschi, F., Bianchi, C., Fornaro, M., Naccarato, G., Menicagli, M., Gomez-Morales, M.A., et al. Matrix metalloproteinase (MMP)-2 and MMP-9 as inflammation markers of Trichinella spiralis and Trichinella pseudospiralis infections in mice. Parasite Immunol. 36 (2014), 540–549.
28. [28] Kwan Tat, S., Padrines, M., Théoleyre, S., Heymann, D., Fortun, Y., IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15 (2004), 49–60.
29. [29] Koch, B., Lemmermeier, P., Gause, A., Wilmowsky, H., Heisel, J., Pfreundschuh, M., Demonstration of interleukin-1beta and interleukin-6 in cells of synovial fluids by flow cytometry. Eur. J. Med. Res. 1 (1996), 244–248.
30. [30] Sasaki, S., Nishikawa, S., Miura, T., Mizuki, M., Yamada, K., Madarame, H., et al. Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect. Immun. 68 (2000), 2424–2430.
31. [31] De Groef, L., Salinas-Navarro, M., Van Imschoot, G., Libert, C., Vandenbroucke, R.E., Moons, L., Decreased TNF levels and improved retinal ganglion cell survival in MMP-2 null mice suggest a role for MMP-2 as TNF sheddase. Mediat. Inflamm., 2015, 2015, 108617.
32. [32] Schönbeck, U., Mach, F., Libby, P., Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol. 161 (1998), 3340–3346.
33. [33] Hu, J., Van den Steen, P.E., Sang, Q.X., Opdenakker, G., Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 6 (2007), 480–498.
34. [34] Mal, P., Dutta, S., Bandyopadhyay, D., Dutta, K., Basu, A., Bishayi, B., Gentamicin in combination with ascorbic acid regulates the severity of Staphylococcus aureus infection-induced septic arthritis in mice. Scand. J. Immunol. 76 (2012), 528–540.
35. [35] Sen, R., Das, D., Bishayi, B., Staphylococcal catalase regulates its virulence and induces arthritis in catalase deficient mice. Indian J. Physiol. Pharmacol. 53 (2009), 307–317.
36. [36] Yao, L., Berman, J.W., Factor, S.M., Lowy, F.D., Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection. Infect. Immun. 65 (1997), 3889–3895.
37. [37] Burchill, M.A., Nardelli, D.T., England, D.M., DeCoster, D.J., Christopherson, J.A., Callister, S.M., et al. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect. Immun. 71 (2003), 3437–3442.
38. [38] Puliti, M., von Hunolstein, C., Bistoni, F., Castronari, R., Orefici, G., Tissi, L., Role of macrophages in experimental group B streptococcal arthritis. Cell Microbiol. 4 (2002), 691–700.
39. [39] Tamura, Y., Watanabe, F., Nakatani, T., Yasui, K., Fuji, M., Komurasaki, T., et al. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J. Med. Chem. 41 (1998), 640–649.
40. [40] Li, H., Mittal, A., Makonchuk, D.Y., Bhatnagar, S., Kumar, A., Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum. Mol. Genet. 18 (2009), 2584–2598.
41. [41] Hultgren, O., Eugster, H.P., Sedgwick, J.D., Körner, H., Tarkowski, A., TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J. Immunol. 161 (1998), 5937–5942.
42. [42] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976 May 7), 248–254.
43. [43] Momi, S., Falcinelli, E., Giannini, S., Ruggeri, L., Cecchetti, L., Corazzi, T., et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J. Exp. Med. 206 (2009), 2365–2379.
44. [44] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
45. [45] Niu, Y., Lu, W., Gao, L., Lin, H., Liu, X., Li, L., Reducing effect of mangiferin on serum uric acid levels in mice. Pharm. Biol. 50 (2012), 1177–1182.
46. [46] Toora, B.D., Rajagopal, G., Measurement of creatinine by Jaffe's reaction–determination of concentration of sodium hydroxide required for maximum color development in standard, urine and protein free filtrate of serum. Indian J. Exp. Biol. 40 (2002), 352–354.
47. [47] Lefkowitz, D.L., Gelderman, M.P., Fuhrmann, S.R., Graham, S., Starnes, J.D. 3rd, Lefkowitz, S.S., et al. Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis. Clin. Immunol. 91 (1999), 145–155.
48. [48] Das, D., Das, A., Analysis of variance. Das, D., (eds.) Statistics in Biology and Psychology, 2005, Academic Publisher, Calcutta, 280–293.
49. [49] Bremell T, Lange S, Yacoub A, Rydén C, Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect. Immun. 1991;59:2615–2623.
50. [50] Matsuno, H., Yudoh, K., Katayama, R., Nakazawa, F., Uzuki, M., Sawai, T., et al. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera. Rheumatol. Oxf. 41 (2002), 329–337.
51. [51] Kanangat, S., Bronze, M.S., Meduri, G.U., Postlethwaite, A., Stentz, F., Tolley, E., et al. Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1beta and IL-1 receptor antagonist. J. Infect. Dis. 183 (2001), 65–69.
52. [52] Shirtliff, M.E., Mader, J.T., Acute septic arthritis. Clin. Microbiol. Rev. 15 (2002), 527–544.
53. [53] Gearing, A.J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:6490 (1994), 555–557.
54. [54] Origuchi, T., Migita, K., Nakashima, T., Tominaga, M., Nakamura, H., Nakashima, M., et al. IL-1-mediated expression of membrane type matrix-metalloproteinase in rheumatoid osteoblasts. Clin. Exp. Rheumatol. 18 (2000), 333–339.
55. [55] Puliti, M., Momi, S., Falcinelli, E., Gresele, P., Bistoni, F., Tissi, L., Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. Arthritis Rheum. 64 (2012), 1089–1097.
56. [56] Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91 (1998), 258–265.
57. [57] Hamza, T., Barnett, J.B., Li, B., Interleukin 12 a key immunoregulatory cytokine in infection applications. Int. J. Mol. Sci. 11 (2010), 789–806.
58. [58] Zhao, Y.X., Nilsson, I.M., Tarkowski, A., The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology 93 (1998), 80–85.
59. [59] Zhang, Y.H., Heulsmann, A., Tondravi, M.M., Mukherjee, A., Abu-Amer, Y., Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. 276 (2001), 563–568.
60. [60] Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D., Mundy, G.R., Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319 (1986), 516–518.
61. [61] Hashizume, M., Hayakawa, N., Mihara, M., IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatol. Oxf. 47 (2008), 1635–1640.
62. [62] Mori, T., Miyamoto, T., Yoshida, H., Asakawa, M., Kawasumi, M., Kobayashi, T., et al. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int. Immunol. 23 (2011), 701–712.
63. [63] Gjertsson, I., Hultgren, O.H., Tarkowski, A., Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin. Exp. Immunol. 130 (2002), 409–414.
64. [64] Glantzounis, G.K., Tsimoyiannis, E.C., Kappas, A.M., Galaris, D.A., Uric acid and oxidative stress. Curr. Pharm. Des. 11 (2005), 4145–4151.
65. [65] Isaacs, J.D., Zuckerman, A., Krishnaswami, S., Nduaka, C., Lan, S., Hutmacher, M.M., et al. Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials. Arthritis Res. Ther., 16, 2014, R158.
66. [66] Pulli, B., Ali, M., Forghani, R., Schob, S., Hsieh, K.L., Wojtkiewicz, G., et al. Measuring myeloperoxidase activity in biological samples. PLoS One, 8, 2013, e67976, 10.1371/journal.pone.0067976.